Siegfried buys BASF drug ingredient businesses for $306 million

May 7, 2015 5:46 AM

10 0

FRANKFURT (Reuters) - German chemicals group BASF (BASFn.DE) has agreed to sell parts of its pharmaceutical ingredients business to Swiss drug contract manufacturer Siegfried Holding (SFZN.S) for 270 million euros ($306 million), including assumed debt.

"Siegfried will reach the critical size to play a leading role in the supplier market as a recognized partner for the pharmaceutical industry," said Siegfried Chief Executive Rudolf Hanko.

Also read: The GOP's Obamacare 'Repeal-And-Delay' Plan Is A Slow Motion Disaster

Read more

To category page

Loading...